Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.72 is 78% below its 5-year average of 21.55, near the low end of its 5-year range (4.72–44.25).
As of the fiscal period ended Tuesday, June 30, 2026. 68.10% below its 12-month average of 14.79.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.72.
CURRENT RATIO
4.72
CURRENT RATIO AVG TTM
14.79
CURRENT RATIO AVG 3Y
25.56
CURRENT RATIO AVG 5Y
21.55
CURRENT RATIO AVG 10Y
23.91
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-68.10%
CURRENT VS 3Y AVG
-81.53%
CURRENT VS 5Y AVG
-78.10%
CURRENT VS 10Y AVG
-80.26%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+25.53%
vs the sector median at left
Viking Therapeutics, Inc.
Market Cap
$3.31B
Current Ratio
4.72
TTM Avg
14.79
3Y Avg
25.56
5Y Avg
21.55
Market Cap
$3.36B
Current Ratio
17.91
TTM Avg
1.68
3Y Avg
1.68
5Y Avg
1.68
Market Cap
$3.38B
Current Ratio
3.39
TTM Avg
3.10
3Y Avg
3.17
5Y Avg
4.31
Market Cap
$3.19B
Current Ratio
3.20
TTM Avg
4.13
3Y Avg
7.45
5Y Avg
12.80
Market Cap
$3.48B
Current Ratio
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
Market Cap
$3.12B
Current Ratio
12.12
TTM Avg
10.47
3Y Avg
8.70
5Y Avg
7.11
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | $3.31B | 4.72 | 14.79 | 25.56 | 21.55 |
| CareDx, Inc (CDNA)vs › | $3.30B | 4.58 | 3.40 | 3.98 | 4.25 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 17.91 | 1.68 | 1.68 | 1.68 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 3.39 | 3.10 | 3.17 | 4.31 |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | 3.20 | 4.13 | 7.45 | 12.80 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 9.63 | 11.21 | 9.89 | 7.80 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.12B | 12.12 | 10.47 | 8.70 | 7.11 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 3.87 | 5.22 | 3.96 | 4.18 |
Current Ratio
4.72
Quick Ratio
4.72
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.72 |
| 2026-03-31 | 5.72 |
| 2025-12-31 | 9.33 |
| 2025-09-30 | 28.34 |
| 2025-06-30 | 25.86 |
| 2025-03-31 | 44.25 |
| 2024-12-31 | 33.09 |
| 2024-09-30 | 36.47 |
| 2024-06-30 | 37.69 |
| 2024-03-31 | 29.48 |
| 2023-12-31 | 19.19 |
| 2023-09-30 | 28.44 |
| 2023-06-30 | 29.63 |
| 2023-03-31 | 9.55 |
| 2022-12-31 | 7.61 |
| 2022-09-30 | 11.74 |
| 2022-06-30 | 12.10 |
| 2022-03-31 | 17.15 |
| 2021-12-31 | 23.98 |
| 2021-09-30 | 19.76 |
| 2021-06-30 | 18.46 |
| 2021-03-31 | 19.35 |
| 2020-12-31 | 21.11 |
| 2020-09-30 | 27.09 |
| 2020-06-30 | 29.89 |
| 2020-03-31 | 32.36 |
| 2019-12-31 | 41.83 |
| 2019-09-30 | 46.71 |
| 2019-06-30 | 52.19 |
| 2019-03-31 | 60.82 |
| 2018-12-31 | 66.40 |
| 2018-09-30 | 64.65 |
| 2018-06-30 | 35.14 |
| 2018-03-31 | 12.42 |
| 2017-12-31 | 2.52 |
| 2017-09-30 | 1.20 |
| 2017-06-30 | 1.85 |
| 2017-03-31 | 4.34 |
| 2016-12-31 | 2.16 |
| 2016-09-30 | 2.57 |
| 2016-06-30 | 3.19 |
| 2016-03-31 | 6.34 |
| 2015-12-31 | 7.69 |
| 2015-09-30 | 3.31 |
| 2015-06-30 | 4.57 |
| 2015-03-31 | 0.01 |
| 2014-12-31 | 0.03 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.04 |
| 2014-03-31 | 0.20 |
| 2013-12-31 | 1.41 |
| 2013-09-30 | 1.41 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.00 |
